Alternatives to AIATELLA

Imorgon provides specialized ultrasound reporting software and advanced reading tools designed to optimize the productivity and accuracy of radiology reports. With automated measurement integration, this software streamlines the reporting process, helping radiologists save valuable time while reducing the likelihood of errors. By enhancing the consistency of measurements and data transfer, it ensures more reliable reports. Imorgon also offers an intuitive, web-based interface for customizable templates, which simplifies report generation and improves overall efficiency. Moreover, its seamless integration with PACS systems allows for smoother workflows, significantly reducing operational bottlenecks in ultrasound departments.

CrelioHealth (formerly LiveHealth) enables customers to deliver a more digital & connected experience. CrelioHealth is used by more than 1500 medical labs and diagnostics centers to provide greater value to patients, doctors, and health organizations. Clear communication and our digital platform have proven to increase patient retention. You can provide seamless patient experience, from booking home collections to receiving reports or making payments via the app, SMS, and WhatsApp. Our integrated online payment system allows patients to make payments and view reports from their smartphone. Your patients can submit feedback directly on the app. Our customers have received over 200k patient feedbacks so far. With our mobile apps and easy interface, you can stay connected to your business at all hours. Instant delivery of reports to patients, doctors, and other organizations will reduce your TAT dramatically.

Altris AI is an advanced, cloud-based clinical decision support system powered by artificial intelligence, specifically tailored to aid eye care professionals in interpreting OCT scans and making informed decisions. The platform streamlines the identification of pathological OCT scans while recognizing over 70 retina-related pathologies and biomarkers, which include some that are quite uncommon. Features of the system encompass severity detection, analysis of retina layer thickness, layer segmentation, and both automatic and manual measurement capabilities. It is designed to work seamlessly with all OCT devices and accommodates various data formats like DICOM, JPEG, and PNG. Furthermore, Altris AI has received FDA clearance, CE certification, and is compliant with GDPR and HIPAA regulations, thereby upholding rigorous standards for data security and patient confidentiality. By integrating this innovative tool into their practices, eye care professionals can significantly enhance patient triage, improve diagnostic precision, and more effectively track the progression of diseases over time. As a result, the adoption of Altris AI not only streamlines workflows but also elevates the overall quality of patient care in eye health.

ProtonPACS, a picture archiving solution, manages image storage, distribution, and optimizes workflow throughout the organization. It offers front and back-end patient management solutions that reduce manual and/or duplicate patient information entry. Integration of HL7 to information systems (EHRs, RISes, etc.) The platform includes this feature. ProtonPACS includes Intelerad's Inteleviewer. This diagnostic viewer gives radiologists and other healthcare professionals the tools to optimize images and change layouts, measure critical points, perform image reconstructions, and create key images. Radiologists can use the integrated speech recognition engine and worklist to create reports for referring doctors. Both reports and images are accessible via any web-enabled device from the system's portal. ProtonPACS uses a secure hybrid model that combines on-premise hardware and cloud hosting.

Riverain Technologies has developed ClearRead Xray, a suite of five applications that have received FDA clearance, aimed at improving the speed and precision of interpreting chest X-rays within healthcare settings, all without the need for extra equipment, procedures, or exposure to radiation. This innovative platform utilizes specialized suppression technology to create a clear view of the chest, which significantly aids in the swift and precise identification of cardiothoracic conditions. Among its standout features are the generation of bone-suppressed images that enhance visualization, the ability to spot potential lung cancer nodules, a decrease in the time required to read portable X-rays, automatic comparisons with previous examinations to emphasize changes, and compatibility across various imaging devices and protocols throughout the enterprise. Additionally, the ClearRead Xray Bone Suppress feature notably enhances soft tissue visibility by minimizing the presence of bone structures in digital images, thereby assisting radiologists in uncovering nodules that may have previously gone unnoticed. This comprehensive approach not only boosts diagnostic capabilities but also streamlines workflow in busy medical environments.

Zebra's Imaging Analytics Engine processes imaging scans from multiple modalities and conducts automatic analyses of various clinical findings, ensuring efficiency and seamless integration with the radiology workflow. Healthcare providers rely on Zebra-Med to notify them about patients who are at elevated risk for cardiovascular, pulmonary, skeletal, and other health issues. This system enhances preventative care initiatives, supports accurate risk adjustments, and aids in meeting quality benchmarks like MACRA. By utilizing Zebra-Med, healthcare professionals can concentrate their efforts on the most vulnerable patients at critical moments, ultimately leading to reduced expenses and enhanced patient care outcomes. Consequently, this innovative approach not only improves the quality of care provided but also optimizes resource allocation across the healthcare system.

Innovative AI solutions that smoothly integrate with your PACS and radiology processes empower radiologists to streamline their workflows and enhance patient care. As the demand for medical imaging continues to rise, radiologists are often overwhelmed by the sheer volume of data, which can lead to increased reporting errors, elevated workloads, and disorganized processes. By automating repetitive tasks and standard measurements, AI technology assists radiologists in producing high-quality, evidence-based reports. This enhancement not only aids referring doctors and physicians in making well-informed decisions but also fosters a more intuitive workflow, ultimately benefiting patient care. Furthermore, these systems excel at identifying, characterizing, and classifying critical elements with pinpoint accuracy while maintaining the highest image quality and ensuring rapid loading times. Additionally, the inclusion of intelligent suggestions during report template searches, along with the ability to use pre-filled or customizable report templates, greatly improves standardized clinical communication and efficiency in the reporting process. By adopting such advanced tools, radiologists can focus more on patient interactions and less on administrative burdens.

The red dot® algorithm we utilize swiftly identifies and highlights irregularities in images with remarkable precision. This advanced AI system has been crafted using a dataset of over 30,000 images, all meticulously evaluated by certified Consultant Radiologists from the UK. With continuous refinement by these highly skilled professionals, our red dot® algorithm maintains an impressive accuracy rate exceeding 90%. The ability to detect abnormalities in mere seconds ensures that patients receive diagnoses even before they leave the hospital. Furthermore, our AI technology enhances current reporting processes and seamlessly integrates with existing Radiology Information Systems (RIS) or Picture Archiving and Communication Systems (PACS), regardless of the vendor. Behold.ai has proven to be a highly cost-efficient solution, effectively alleviating reporting backlogs and capacity challenges while being up to 50% less expensive than outsourced reporting options. Recognized globally, behold.ai has earned a spot among the Top 100 Digital Health companies and is one of only five selected for AI diagnosis worldwide, showcasing its commitment to innovation in healthcare. This recognition underscores the transformative impact our technology is having on medical diagnostics and patient care.

InformAI specializes in artificial intelligence solutions designed to enhance medical diagnostics at the point-of-care and boost the efficiency of radiologists. Our advanced AI-driven image classifiers and predictions related to patient outcomes are developed in collaboration with the Texas Medical Center, which is the largest medical center complex globally. Through partnerships with esteemed healthcare organizations, prominent physician associations, and top medical imaging firms, InformAI is revolutionizing healthcare delivery. Our team is made up of experts in the fields of healthcare, medicine, and artificial intelligence, working together to create innovations that lead to better patient results. One of our notable products, the InformAI Sinus Image Classifier, utilizes a 3D convolutional neural network (CNN) and is trained on a comprehensive library of 6 million radiology-validated 3D CT-scan images, showcasing our commitment to leveraging cutting-edge technology in the medical field. This approach not only enhances diagnostic accuracy but also contributes to more timely and effective patient care.

PowerScribe One represents an advanced radiology reporting solution that utilizes artificial intelligence to enhance both diagnostic precision and workflow productivity. By leveraging Microsoft Cloud for Healthcare, this platform automates key elements of the radiology reporting process, such as creating initial impressions and providing immediate clinical insights. Its innovative features, which include Smart Impression and AI-driven findings, empower radiologists to generate comprehensive reports more swiftly and with reduced mistakes. Additionally, PowerScribe One facilitates smooth connectivity with electronic medical records (EMR) and incorporates cloud-based speech recognition technology, leading to more accurate documentation. This combination not only streamlines the reporting process but also significantly contributes to better patient care and outcomes. Ultimately, the integration of these technologies positions PowerScribe One as a vital tool for modern radiology practices.

Qure.ai's qLC-Suite is a cutting-edge AI-driven tool aimed at improving the early identification and management of lung nodules, which is crucial for prompt lung cancer intervention. This solution delivers accurate measurements, thorough characterization, and 3D imaging of lung nodules, ensuring that opportunities for early treatment are not overlooked. It is capable of supporting both incidental and targeted screenings by efficiently identifying nodules and calculating their volume with just one click. Moreover, the system monitors volumetric changes over time, providing valuable insights into nodule development. The qLC-Suite is designed to integrate smoothly into current workflows, offering quick analysis and reporting that assist healthcare professionals in their decision-making processes. In addition to its analytical capabilities, it serves as a comprehensive platform for managing lung nodules, facilitating care coordination through intelligent prompts, providing hardware-agnostic image viewing for AI-enhanced chest X-rays and CT scans, enabling seamless sharing of scans across departments, and allowing for tailored notifications for cases of concern. Overall, qLC-Suite represents a significant advancement in lung cancer care, promoting timely interventions that can ultimately save lives.

Version 8.0 of PDQuest 2-D analysis software provides a robust and adaptable platform for conducting 2-D gel electrophoresis analysis. Users can opt for PDQuest Basic for straightforward 2-D gel evaluations or PDQuest Advanced to access the most cutting-edge features designed for in-depth expression proteomics research. Regardless of the version selected, the advanced analytical tools effectively highlight subtle variations across different 2-D gels. The software employs powerful auto-matching algorithms that ensure quick and precise gel matching with minimal manual effort. Furthermore, PDQuest's versatile annotation capabilities make it an invaluable asset for creating a centralized database, enabling a wide array of characterization data to be associated with each spot on a master gel image. Sharing and reviewing information related to identified proteins is made simple and efficient. Additionally, the software offers adaptable spot cutting configurations that enhance accuracy, throughput, and flexibility in protein identification trials, making it an essential tool for researchers in the field.

Realize Medical's Elucis is an FDA-approved extended reality platform that simplifies the segmentation of images, promotes collaboration among remote teams, and allows for procedural planning in a virtual reality space. Elucis is capable of handling an unlimited number of 3D and 4D CT and MR images, ensuring thorough project integration. It boasts cutting-edge image processing features, including both manual and automatic registration, as well as the display of images in 2D, 3D, and 4D formats. The platform’s segmentation tools are engineered for efficiency and user-friendliness, enabling precise measurement, cutting, and planning tasks directly in a virtual environment. Additionally, Elucis includes advanced 4D modeling capabilities that permit intricate segmentation of cardiac structures in mere minutes, regardless of the phase. Users have the flexibility to import 3D structure files from external sources and can easily export their work with a single click. Furthermore, the platform enhances teamwork by allowing multiple users to connect seamlessly with local or remote colleagues throughout the entire workflow, making it a versatile tool for medical professionals. This feature not only streamlines communication but also ensures that all stakeholders can contribute effectively to the project.

Pulse is a cloud-based solution designed for echocardiography labs aiming to enhance efficiency and patient outcomes. This platform facilitates reporting, storage, and analysis of echocardiograms, ensuring that you can access patient information whenever and wherever it's needed. Physicians benefit from the ability to review studies and finalize reports from virtually any location, making it an essential tool for contemporary echocardiography practices. With a user-friendly and robust reporting interface conveniently located alongside images and measurements, Pulse empowers users to navigate their tasks seamlessly. Its AI-driven features allow for fully automated measurements of GLS, LVEF, LVEDV, and LVESV, eliminating the need for manual input. Furthermore, the platform minimizes security risks while maximizing the advantages associated with cloud-native technology. Reports can be sent directly to your electronic health record (EHR) via HL7, effectively streamlining clinical workflows. You can easily store new studies right from the cart or retrieve existing studies from an external PACS. Moreover, integrated support for DICOM-TLS simplifies the management of secure data access, sparing users from the complexities of VPN setups. Overall, Pulse is revolutionizing the way echocardiography labs operate by combining technology with clinical expertise.

Join AI is transforming the healthcare landscape with AI-powered tools designed to assist in radiology and endoscopy diagnostics. The platform offers AI-driven solutions for chest imaging, breast imaging, stroke detection, and gastrointestinal endoscopy, enabling clinicians to detect conditions like lung diseases, breast tumors, and gastrointestinal infections more efficiently. Join AI’s algorithms provide deeper insights, aiding in early diagnosis and faster decision-making, which are crucial for improving patient care and treatment outcomes. With seamless integration into existing workflows, the platform empowers healthcare professionals to make more confident decisions.

Arterys is an innovative medical imaging AI platform that seamlessly integrates advanced AI clinical applications into your existing PACS or EHR workflows, making it an intuitive extension of your current practices. Our goal is to bring AI into the forefront by enhancing physician experiences, improving diagnostic accuracy and treatment efficacy, optimizing financial outcomes, and providing significant benefits for both patients and healthcare providers. Accessible from any validated device through the cloud, it offers rapid performance and easy deployment without the exchange of PHI, ensuring complete security. Fully connected to PACS, RIS, EMR, and dictation software, Arterys enhances your workflow without disruption. Its rapid deployment capabilities require minimal on-premise infrastructure, and it is commercially available in more than 100 countries. The platform's elastic cloud GPU architecture significantly boosts the performance of various tasks, such as rendering complex 3D files, handling large multi-dimensional datasets, and executing multiple AI applications simultaneously in real time. Additionally, features like pre-fetching and image caching contribute to quicker loading times and more efficient analysis, making it an indispensable tool in modern healthcare. This comprehensive approach positions Arterys as a leader in transforming medical imaging through artificial intelligence.

WRDensity supports radiologists in evaluating breast density, promoting consistency in density assessments across their practices. Its primary aim is to facilitate early detection while ensuring patients feel reassured through enhanced consistency, confidence, and overall quality of care. Developed using advanced deep learning techniques, WRDensity analyzed over 600,000 images sourced from the esteemed Mallinckrodt Institute of Radiology, known for its pioneering work in the field. This robust deep learning model excels in providing precise classifications of breast density. Additionally, the batching and sorting features can boost user productivity by as much as 20%. By integrating WRDensity into the radiologist's existing workstation, critical information regarding tissue density is readily accessible in a relevant context, further enhancing the diagnostic process. Ultimately, this innovation not only streamlines the workflow but also contributes to improved patient outcomes.

CARPL.ai serves as a vendor-agnostic artificial intelligence platform designed to empower radiologists in accessing, evaluating, and incorporating a wide range of radiology AI solutions into their everyday clinical workflows. This innovative platform boasts an extensive collection of over 140 AI applications from more than 60 different vendors, thereby aiding in the discovery, exploration, validation, and implementation of various AI tools. By providing a unified technical integration along with a user-friendly interface, CARPL.ai simplifies the process of adopting multiple AI systems effectively. The platform is versatile, accommodating both cloud-based and on-premise deployments to suit diverse clinical settings. Additionally, it features a universal AI viewer that allows for the viewing, editing, and annotating of AI-generated outputs while also providing pre-deployment validation and ongoing post-deployment monitoring to maintain the systems' performance over time. With seamless integration into existing Picture Archiving and Communication Systems (PACS), CARPL.ai enhances patient care, minimizes turnaround times, and boosts diagnostic accuracy, ultimately transforming the radiology landscape for better healthcare outcomes. Furthermore, its commitment to adaptability and ease of use makes it a valuable asset for radiologists looking to leverage AI technology in their practices.

Healthcare providers can offer optimal treatment when equipped with advanced and user-friendly technology. Enhance your efficiency with our top-tier cardiovascular imaging solution. Drawing from over ten years of experience in streamlining workflows, we focus on improving your practice. Effortlessly identify wall motion abnormalities with our system. Key metrics such as stroke volume, ejection fraction, as well as end-diastolic and end-systolic volumes and masses are automatically displayed. Evaluate intricate cardiovascular structures through both 2D and 3D visualization options, along with a variety of measurement tools. Our solution delivers objective, automated quantitative analysis of myocardial blood flow, achieving expert-level precision without user bias. Additionally, it allows for the visualization and quantification of enhanced fibrosis distribution. In the DICOM images, colored lines indicate corresponding areas in the ADAS 3D image for each slice, facilitating a comprehensive understanding of the patient's condition. By integrating these features, we aim to empower healthcare professionals with the insights needed for informed decision-making.

Our innovative AI solutions are crafted to enhance the capabilities of healthcare professionals at critical stages of the medical process. Whether it's during preventive screenings, early diagnosis, emergency interventions, managing institutional disease outbreaks, or ensuring treatment compliance, we facilitate a smooth optimization of workflows throughout the entire care spectrum. By partnering with esteemed healthcare authorities and leveraging vast amounts of data to inform our algorithms, we ensure that our AI meets the highest global regulatory requirements. Supported by extensive research in data science, our offerings are designed to predict healthcare needs, especially in challenging situations. Our AI solutions are primed for immediate use, adaptable to various settings and situations as necessary. They seamlessly integrate with your existing technology framework and can be customized to work with your preferred devices. We provide straightforward deployment and scaling options while guaranteeing top-tier data security that complies with industry standards. Additionally, our dedicated team is committed to guiding you through every phase of your AI implementation journey, ensuring you feel confident and supported. With our solutions, you can transform your healthcare delivery and improve patient outcomes significantly.

Clario’s Imaging Platform offers a secure and efficient solution that ensures precise results for clinical trials of varying complexities. We utilize our in-house medical specialists and proprietary imaging technologies to tailor your workflow and analysis according to your specific requirements. By employing our dedicated engineering teams, you can avoid the additional costs and time delays commonly associated with third-party systems. As the leading Imaging Core Lab globally, Clario boasts a team of over 30 physicians and 35 scientists who specialize in medical imaging. Our extensive experience in evaluating and analyzing medical images has significantly shaped the evolution of our proprietary imaging solutions. The SMART Submit application from Clario integrates this wealth of expertise at every stage, beginning with the initial screening of medical images for errors at the hospital and continuing through to the final interpretation of the images. In doing so, we ensure that every aspect of the imaging process meets the highest standards of quality and accuracy.

MiNNOVAA is a company specializing in medical information technology, particularly in the realms of medical imaging software and the exchange of medical images. With the guiding principle of "medical imaging innovation," we stand out for our nimbleness and the state-of-the-art technology we utilize in crafting our solutions. Our main areas of concentration are the development of medical image viewers, enhancement of radiology workflows, and the incorporation of artificial intelligence in diagnostic reporting. Our energetic team comprises around 20 skilled programmers and product managers, alongside professionals in marketing, sales, technical support, call center operations, and administration, all dedicated to driving a meaningful transformation in the field of medical imaging and enhancing individual healthcare experiences. We offer a comprehensive clinical imaging IT solution tailored for mid-sized hospitals and imaging clinics, featuring a wide array of functionalities such as on-premise core PACS software, a DICOM web viewer, multi-platform imaging workstation software, seamless integration with EHR/EMR/HIS systems, and an efficient workflow engine/RIS. Ultimately, our commitment to innovation and comprehensive solutions aims to redefine how medical imaging is approached and utilized within healthcare settings.

Ambra Health offers an advanced cloud-based platform designed for the management of medical data and images, catering to hospitals, radiology practices, medical groups, and contract research organizations. This platform is scalable, user-friendly, and highly compatible with other systems, enabling healthcare providers to enhance collaboration through seamless image sharing with patients and various departments. With Ambra’s secure storage solution, users can consolidate all imaging data into a unified repository, accommodating a wide range of medical imaging file formats such as TFF, JPEG, and DOC among others. Key functionalities of the platform include an EMR HL7 Bridge, integration with PACS, a Cloud VNA, EMR/EHR integration, telestroke services, and an informatics-first migration approach. Ambra Health not only streamlines the management of medical images but also ensures compliance with industry standards, thereby promoting better patient care and operational efficiency. These features make it a crucial tool for organizations aiming to optimize their imaging workflows in a rapidly evolving healthcare landscape.

Hospitals and imaging facilities are overwhelmed by the influx of discs from various external sources. The process of manually importing this data proves to be both labor-intensive and expensive. However, with the implementation of the Automated Disc Importer, these organizations can efficiently transfer large quantities of discs into either temporary cloud storage or local systems without requiring human assistance. After the discs are processed, users are able to validate the data before it is officially archived. Additionally, this system enhances security by capturing an image of each disc label during the reading process, which aids in maintaining a comprehensive audit trail. These photographs not only document the imports but also specify the origin of each disc. By leveraging the Automated Disc Importer, medical images and reports from DICOM discs are effectively processed, significantly minimizing the time previously dedicated to manual data entry, and improving overall workflow efficiency. This innovation represents a substantial advancement in the management of medical imaging data.

Enhance patient care by using the only objective, quantitative arterial analysis software validated through histology and based on CTA technology. This innovative tool employs ground-truth histological data to reveal the origins of myocardial ischemia, helping to assess risks for heart attacks and strokes. These critical events are often driven by unstable, non-obstructive plaques within the arteries that remain undetected and unaddressed. Traditional non-invasive diagnostic methods fall short, as they cannot penetrate deep into the arterial walls where heart disease begins to manifest. Elucid is leveraging advanced scientific imaging alongside artificial intelligence to facilitate rapid, reliable, and non-invasive diagnoses, ultimately leading to tailored treatment strategies for cardiovascular conditions and improved patient outcomes. With this histology-validated software, you can evaluate plaque composition and determine the risks of heart attacks and strokes with unmatched precision. This comprehensive, objective visualization of arterial health empowers healthcare providers to devise customized treatment approaches well before a patient arrives for hospital care, significantly enhancing the quality of healthcare delivery.

Solventum Fluency for Imaging is an innovative AI-driven solution designed for radiology reporting that seamlessly integrates advanced speech recognition capabilities with immediate clinical insights, efficient workflow management, and tools aimed at boosting productivity to enhance quality, compliance, efficiency, and cost-effectiveness. This software maintains existing workflows while transforming dictations into precise, high-quality documents that are well-structured, clinically encoded, easily searchable, and readily shareable. It employs natural language understanding to accurately interpret the context of radiologists' dictations and includes built-in computer-assisted physician documentation, offering automated and interactive clinical insights directly within the reporting process. Additionally, the solution features customizable templates, personalized macros, and workflow enhancements such as actionable findings management and peer reviews, all aimed at ensuring thorough capture, documentation, and communication of patient outcomes. By integrating these functionalities, Solventum Fluency for Imaging significantly improves the overall efficiency of the radiology reporting process.

Effortlessly identify the suitable landing zone for the treatment of abdominal aneurysms (EVAR), thoracic aneurysms (TEVAR), or the insertion of fenestrated stents (FEVAR). All necessary metrics, including diameter, clock position, volume, and length, can be accurately acquired through automatically detected centerlines or 3D double oblique imaging. Furthermore, integrated manufacturer stent order sheets can create PDF files, simplifying the process of ordering specific stents via email. Our ongoing mission is to enhance the quality and efficiency of cardiovascular image analysis, which in turn optimizes patient treatment outcomes. We strive to align our product offerings with the most recent advancements in the cardiovascular sector. By doing so, we ensure that our customers receive the best software solutions at the most opportune moments. Recognizing the significance of proper training and support, we are committed to making sure all users are proficient and comfortable with their analysis. To meet diverse needs, we provide customizable training options that adapt to individual requirements, fostering a supportive learning environment for all users.

The SenseCare Smart Health Platform, created by SenseTime, represents a powerful diagnostic and treatment support tool that integrates cutting-edge AI algorithms with sophisticated image post-processing capabilities. Leveraging extensive medical big data, this platform is designed to offer intelligent solutions for multiple clinical departments, enhancing the entire cycle of diagnosis, treatment, and recovery while increasing the precision and effectiveness of doctors' planning and decision-making processes. Furthermore, SenseCare allows for effortless integration with existing CT, MRI, and X-ray devices, as well as PACS, without disrupting the established workflows within healthcare facilities. Users across the hospital can conveniently log into the platform and conduct analyses through web browsers on a range of portable devices, eliminating the need for additional plug-ins. The system also supports a variety of automated 3D post-processing techniques, including MPR, CPR, and VR, thereby streamlining the workflows associated with diagnosis, treatment, and rehabilitation. By facilitating these processes, SenseCare not only enhances operational efficiency but also fosters improved patient outcomes through more effective healthcare delivery.

The INFINITT Cardiology Suite serves as a comprehensive platform that consolidates all cardiovascular information into a single solution, enhancing the management, analysis, reporting, and submission of images to various data registries. Furthermore, it has received certification from the American College of Cardiology (ACC), confirming that version 1.0.8.1 of the INFINITT Cardiology Suite complies with the NCDR standards for the CathPCI Registry® version 5. This suite functions as an online PACS and reporting tool tailored for cardiology and vascular imaging, as well as EKG and nuclear medicine applications. It can operate independently or integrate seamlessly with INFINITT PACS, thereby unifying data for electronic health records (EHR). Users can customize report templates that are compatible with Dragon Dictation, allowing for flexibility and efficiency. Additionally, the suite offers both basic and advanced measurement tools for echocardiography, non-invasive vascular imaging, EKG, nuclear medicine, and cardiac catheterization studies. It provides sophisticated report generation capabilities, including the automatic population of measurements and interpretations, which significantly reduces transcription expenses and enhances workflow efficiency. This integration leads to improved patient outcomes through timely access to comprehensive data.

BrainSightAI is an innovative health technology firm that harnesses the power of artificial intelligence and machine learning to transform the field of brain mapping through AI-driven connectomics, allowing for the creation of customized brain maps. The VoxelBox product line employs these AI techniques to produce individualized brain maps tailored to each patient's needs. These advanced tools are specifically designed to facilitate pre-surgical preparation and enhance patient outcomes for those suffering from brain tumors and various neurological issues. Collaborating with top hospitals across the country, BrainSightAI is engaged in clinical trials that explore a range of brain-related ailments such as Alzheimer's disease, brain tumors, psychiatric disorders, Parkinson's disease, and stroke. Committed to pushing the boundaries of brain science, our overarching goal is to improve quality of life by offering state-of-the-art resources that deepen our understanding of the human brain and its complexities. By continually refining our technology and methodologies, we aspire to make significant contributions to the medical community and the lives of patients.

Our innovative AI solution empowers healthcare practitioners to conduct high-quality ultrasound examinations anytime and anywhere, irrespective of their experience level with ultrasound technology. While ultrasound serves as a reliable and effective diagnostic instrument, mastering its use can be challenging, requiring extensive specialized training and often resulting in variable image quality. The examination process demands precise hand-eye coordination and can be visually unintuitive, complicating the learning curve. Moreover, conventional ultrasound software fails to provide guidance on how to maneuver the ultrasound transducer effectively or offer immediate feedback regarding the clarity of the images obtained. This can lead to subpar imaging, which in turn results in overlooked diagnoses, unnecessary repeat exams, and inconsistent interpretations of the results. Consequently, the full potential and advantages of ultrasound technology have not been completely harnessed. With the advent of our AI-driven technology, any healthcare provider can now effortlessly capture high-quality diagnostic ultrasound images, as the AI assists them throughout each phase of the scanning procedure, ensuring accuracy and efficiency. This advancement not only enhances the diagnostic capabilities of healthcare providers but also promotes better patient outcomes through timely and accurate assessments.

Us2.ai is revolutionizing the battle against heart disease by utilizing AI-driven ultrasound software that ensures heart health can be accessible to everyone. This innovative platform provides 45 automated echo parameters, such as strain analysis, and enables real-time interpretation of 2D and Doppler images. It seamlessly integrates with any ultrasound machine, producing zero-click, comprehensive reports that maintain high accuracy and can be easily compared with expert evaluations. The AI echo copilot from Us2.ai autonomously analyzes all heart chambers through both 2D and Doppler perspectives, incorporating global reference guidelines into detailed, real-time reports. Recently, the software obtained FDA clearance for Us2.v2, which also boasts 45 automated echo parameters, including strain analysis, representing a remarkable advancement in healthcare technology. Ultimately, Us2.ai aims to democratize echocardiography, ensuring that ultrasound technology is available to individuals regardless of their location or circumstances, thereby promoting better heart health for all. This commitment to accessibility and innovation positions Us2.ai at the forefront of the medical technology landscape.

RedBrick AI serves as a rapidly collaborative platform for annotating medical data, specifically designed to assist healthcare AI teams in creating high-quality training datasets across various types of radiological imagery, including CT, MRI, X-ray, Ultrasound, Fluoroscopy, and additional standard imaging techniques. The platform is adept at managing intricate tasks such as multi-series annotation and extensive DICOM studies, thanks to its native compatibility with medical data formats including DICOM and NIfTI. Furthermore, it boasts cutting-edge, user-friendly 2D and 3D web-based annotation tools, complemented by a PACS-like viewer. RedBrick AI supports a wide array of annotation use cases, including instance and semantic segmentation, landmark identification, classification, and ROI measurements, thereby enhancing the speed of annotation processes by as much as 60%. This significant improvement in efficiency can empower healthcare professionals to focus more on patient care rather than on time-consuming data preparation tasks.

HeartFlow offers a groundbreaking, non-invasive cardiac test that delivers detailed visualizations of individual coronary arteries, allowing doctors to develop more tailored treatment strategies for their patients. The process begins when a patient has a standard coronary computed tomography scan performed at a medical facility. Following this scan, the CT images are securely sent to our cloud-based system. Utilizing cutting-edge algorithms powered by artificial intelligence, we create a customized digital representation of the patient's coronary arteries. Our skilled analysts then review this model, making necessary adjustments to ensure accuracy. After finalizing the patient-specific model, the HeartFlow pathway employs physiological principles and computational fluid dynamics to analyze blood flow and compute FFRCT values throughout the model. We adhere to strict and well-established protocols throughout this entire process, ensuring uniform processing for every individual patient, which ultimately enhances the quality of care provided. This innovative approach not only improves diagnostic precision but also empowers healthcare providers to make informed decisions for optimal patient outcomes.

Medis Suite XA serves as our comprehensive solution for X-Ray angiography, built upon over three decades of expertise in cardiovascular image analysis. This all-inclusive package features an array of modules, including a user-friendly viewer and various analyses dedicated to coronary and vascular assessments, enabling detailed anatomical evaluations of arteries. It also encompasses analyses for both left and right ventricles along with integrated reporting capabilities. Among its offerings are advanced analyses for coronary and peripheral vessels (QCA and QVA) as well as left and right ventriculograms (QLV and QRV). A standout feature is the innovative QFR® analysis, which evaluates the functional significance of lesions without requiring adenosine or a pressure wire. Moreover, the suite allows for seamless integration within the healthcare IT infrastructure, ensuring effortless connectivity with the DICOM network, thus enhancing workflow efficiency and patient care. Ultimately, Medis Suite XA represents a significant advancement in the field of cardiovascular imaging.

Enhance your examination capabilities from any location and boost patient outcomes with intuitive, real-time imaging that is both economical and highly portable. Introducing the groundbreaking 3rd generation portable ultrasound, which is now 30% smaller and lighter than its predecessors. The Clarius HD3 offers unparalleled portable ultrasound technology tailored for your specific specialty, featuring a user-friendly app driven by artificial intelligence and seamlessly integrated with cloud connectivity. With the Clarius HD3, you can expect crisp and clear imaging that makes it simple to pinpoint anatomy, accurately diagnose conditions, and guide procedures in real-time right at the patient's side. This innovative device is equipped with artificial intelligence, 192 piezoelectric elements, and an impressive eight beamformers, which together provide the superior performance typically associated with cart-based systems, all while maintaining the lightweight feel of a conventional probe. As we move towards a future where smart devices operate without ports, the Clarius HD3 incorporates cutting-edge antenna technology designed for the most dependable direct WiFi connection to your mobile iOS or Android devices, eliminating the need for ports or cables altogether, thus ensuring maximum convenience. This advancement represents a significant leap forward in diagnostic imaging technology.

Quantib Brain is a radiology software solution that has received FDA clearance and CE marking, specifically designed for the segmentation of brain scans. Collaboratively developed with GE Healthcare, it operates as a plug-in for the Advantage Workstation (Server), delivering automated quantification of brain structures in a user-friendly software setting. This innovative tool allows for the longitudinal analysis of brain volume measurements, encompassing white matter, grey matter, intracranial volume, and cerebrospinal fluid, which aids in monitoring the progression of atrophy. Furthermore, it includes functionality for the segmentation and tracking of white matter hyperintensities. Quantib Brain offers a detailed summary of volumes for grey matter, white matter, ICV, CSF, and total brain volume, all presented in a clear results table. Users can also benefit from self-selected cross-sections, which can be easily exported into a detailed report, ensuring all examination findings are readily shareable for collaborative review. This capability enhances the overall efficiency of diagnosis and patient management in clinical settings.

NeuroQ stands out as a premier software for brain imaging analysis, delivering a robust diagnostic resource applicable across various modalities and clinical scenarios. This comprehensive tool supports an array of imaging techniques, including FDG, Amyloid, SPECT, DaTscan, and Epilepsy, thereby enhancing diagnostic precision in differentiating between various conditions. As one of the most prevalent quantitative instruments utilized in the differential diagnosis of dementia, NeuroQ transcends simple visual evaluations by offering crucial, objective diagnostic insights. It efficiently assesses metabolic levels across over 240 predefined brain regions, contrasting them with a normative database to quantify the extent of abnormalities and their statistical significance. Designed to assist in the evaluation of human brain scans, NeuroQ meticulously quantifies mean pixel values within standardized areas of interest and allows for detailed comparisons with other brain images, ultimately contributing to better patient outcomes. This innovative software is essential for clinicians seeking reliable data to inform their diagnostic processes and treatment decisions.

A cloud platform that is accessible from anywhere, infinitely scalable, and powered by AI offers collaborative features while adhering to the strictest security and compliance standards. This user-friendly software, designed by specialists in neuroimaging and data science, addresses the specific and complex requirements of the neuroscience field. Customized to suit your particular needs, it supports a wide range of activities, including research, clinical trials, point-of-care applications, algorithm development, and the utilization of brain-related data. The platform facilitates global data aggregation and consolidates imaging studies into a single cloud environment. It provides an efficient, comprehensive management solution for clinical, real-world data, and medical imaging information. Users receive tailored, expert assistance throughout their studies to ensure successful outcomes. Additionally, it features centralized reading capabilities and the option to compare quantitative results against a normative database. The platform also guarantees high-quality, shareable reporting and data export options to streamline the submission approval process, making it an invaluable tool for neuroscience professionals. Furthermore, its innovative design enhances collaboration among researchers and clinicians, fostering a community dedicated to advancing the field.

Three Palm Software has developed a breast imaging workstation named WorkstationOne, which features a unique approach to enterprise integration and interpretation workflow. Recognizing the challenges faced by radiologists transitioning to digital mammography, the company emphasizes the importance of enabling efficient reviews of digital mammograms that match the speed of traditional film readings on motorized lightboxes. The workstation boasts a sleek and user-friendly interface tailored to accommodate the rigorous demands of radiologists. It employs advanced viewing strategies, such as Tabár’s systematic viewing mask techniques, to enhance the detection of subtle radiographic abnormalities. Users can navigate full-resolution images seamlessly with a mouse wheel, allowing for visual tracking of pixels that have already been examined, thus eliminating the need for manual panning and zooming to ensure all pixels are viewed in their highest clarity. This innovation not only streamlines the workflow but also enhances diagnostic accuracy for healthcare professionals.

Oncoustics is pioneering the development and application of innovative, patented AI technologies aimed at providing low-cost, non-invasive surveillance, diagnostics, and treatment monitoring for diseases that currently face significant clinical challenges. The company has developed a range of specialized applications focused on various diseases and anatomical structures that are compatible with any point-of-care ultrasound device, allowing physicians, nurses, and technicians to operate them as essential tools in a primary care setting without requiring image analysis. By leveraging AI, Oncoustics transforms affordable point-of-care ultrasound machines into robust diagnostic instruments capable of facilitating quick and economical identification and monitoring of conditions affecting the liver, prostate, kidney, breast, and thyroid. The multidisciplinary team behind Oncoustics consists of professionals with expertise in AI, signal processing, radiology, hepatology, digital health, and ultrasound, ensuring a comprehensive approach to healthcare innovation. The emphasis on cost-effective point-of-care diagnostics and surveillance significantly enhances patient outcomes through timely detection and consistent monitoring, which are crucial for effective disease management and better overall health. As such, Oncoustics is not only addressing immediate healthcare needs but is also setting the stage for a transformation in how we approach disease management in the future.

Our comprehensive cloud-based platform enables you to streamline your facility or health system’s radiology services under a single contract, effectively reducing expenses while maintaining the quality, dependability, and accessibility of imaging studies. BRIT Systems stands at the forefront of innovative imaging solutions tailored for the healthcare sector. This unified cloud solution not only consolidates radiology services under one agreement but also significantly cuts costs. Additionally, the company provides a quality control module aimed at improving performance across various radiology ecosystems, thereby delivering added value for both healthcare facilities and their patients. By delving into the various modules within our cloud-based solution, you can assess how each contributes to enhancing value for our partner facilities and the patients they serve. It's important to note that no radiology solution fits all scenarios perfectly. We understand that our extensive range of services might exceed the needs of some facilities. Therefore, once any of our services are integrated into your facility, you can easily access additional modules as necessary to meet your specific requirements. This flexible approach ensures that every facility can tailor their radiology offerings to best serve their unique circumstances.

AI plays a crucial role in identifying early-stage cancers, facilitating prompt interventions that enhance survival prospects. Cancer's intricate nature means that each type carries distinct characteristics, packed with extensive data that requires thorough analysis. This is where AI excels, leveraging its capabilities to process complex information, ultimately revealing insights that can significantly aid in cancer treatment strategies. Equipped with precise and relevant data, we take proactive steps in our battle against cancer. By utilizing AI, we are poised to make substantial strides in overcoming this disease. Our AI technology is designed to detect early-stage cancer with remarkable accuracy, achieving detection rates between 97-99%. It proficiently identifies ten of the most prevalent abnormalities found in chest x-rays, thus enhancing one of the most fundamental diagnostic tools. This innovation not only streamlines the radiology workflow but also alleviates the workload for radiologists. Lunit INSIGHT CXR successfully encompasses a wide range of findings, ensuring that we are prepared to tackle the challenges presented by cancer detection and treatment. The future of cancer care looks promising with AI at the forefront of these advancements.

CureMetrix harnesses the capabilities of Artificial Intelligence (AI) to enhance technology aimed at bettering disease detection and boosting cancer survival rates on a global scale. Our mission is centered on equipping radiologists with state-of-the-art tools that facilitate their assessment of mammograms, ultimately leading to enhanced clinical and financial results, as well as greater confidence for imaging centers, healthcare systems, and the patients they serve. Initial research involving thousands of images indicates that our innovative algorithm has the potential to decrease false-positive rates, which can help avoid unnecessary follow-up procedures and alleviate patient anxiety. We are committed to creating advanced technology that allows healthcare providers to detect even the smallest changes more swiftly and accurately than ever before. Our image analysis platform is specifically engineered to enhance the evaluation of dense breast tissue through mammography, thereby improving diagnostic accuracy and patient care. As we continue to refine our technology, we remain focused on the impact it can have on the future of medical imaging and patient outcomes.

Radiolens is an innovative PACS radiology workflow solution powered by AI that enhances diagnostic processes by automatically identifying low-quality scans and generating preliminary reports for various common modalities. This system promotes clinical collaboration and improves workflow efficiency, leading to better-informed decision-making. It features automated task assignments to optimize workload distribution and provides actionable insights that are both quantitative and qualitative, enhancing the speed and accuracy of reporting. Additionally, it includes a lightweight DICOM Viewer that allows users to access cases from mobile devices, thereby eliminating the need for on-site presence with its cloud-based solution. Users receive real-time notifications on their devices, ensuring timely updates. With top-notch accuracy, unlimited image backup, and straightforward archiving capabilities, Radiolens also delivers instant AI-evaluated biomarkers for essential qualitative and quantitative metrics such as CCAP diameter, listhesis, compression fractures, IV disc height, and thecal sac measurements. Its intelligent server automatically matches templates to studies based on the patient's gender and the modality being used, streamlining the workflow further. This comprehensive approach not only enhances the efficiency of radiology departments but also significantly elevates the quality of patient care.

Cleerly is a pioneering digital health organization that is revolutionizing how healthcare professionals manage heart disease. Our innovative clinical technologies are designed to enable clinicians to detect and accurately characterize atherosclerosis at an earlier stage, allowing for the development of customized and potentially life-saving treatment strategies for patients throughout their healthcare journey. Rather than relying on indirect indicators like risk factors or symptoms, we focus on measuring atherosclerosis directly, which is the accumulation of plaque in the arteries of the heart. By utilizing our AI-driven digital care pathways, we provide streamlined, rapid, and precise diagnostics and reporting that cater to the needs of all stakeholders, leading to enhanced clinical and financial results. Cleerly equips healthcare providers to transcend conventional assessments of heart disease by thoroughly analyzing, characterizing, and quantifying various plaque types. This advanced approach enables clinicians to better assess a patient's likelihood of experiencing a heart attack and to formulate effective treatment plans that aim to enhance overall heart health, ultimately fostering improved patient outcomes and quality of care.

OsiriX is a highly esteemed medical imaging software designed for viewing DICOM (Digital Imaging and Communications in Medicine) files, catering especially to healthcare professionals who require efficient management and analysis of medical images. This versatile platform boasts capabilities for 2D, 3D, and 4D visualization, complemented by sophisticated post-processing tools that enhance diagnostic precision. Its advanced features, including volume rendering and detailed image manipulation, make it a preferred choice among radiologists, clinicians, and researchers worldwide. Available in two versions, OsiriX provides a free (Lite) option alongside a paid (MD) version that includes enhanced functionalities and necessary certifications for clinical application, such as FDA and CE approvals. Additionally, the software's user-friendly interface and robust performance contribute to its widespread adoption in the medical community.

Created by radiologists for their peers, our initiative harnesses AI technology to help radiologists save time, alleviate burnout, and enhance the quality of patient care. Rad AI Continuity ensures that follow-up recommendations for important incidental findings in radiology reports are effectively addressed, leading to better patient outcomes, minimizing health system risks, and generating new financial benefits. With up to 35% reduction in dictated words and over an hour saved during each shift, our solutions significantly boost operational efficiency while also capturing previously overlooked revenue. Established by a skilled team with extensive knowledge in healthcare and artificial intelligence, our venture is supported by prominent investors and has gained the trust of leading radiology groups across the country. This commitment to innovation helps reshape the future of radiology, ultimately benefiting both practitioners and patients alike.

See-Mode Technologies is a MedTech firm focused on utilizing AI to enhance ultrasound reporting, thereby boosting both diagnostic accuracy and operational efficiency. Their innovative platform swiftly analyzes ultrasound images of the thyroid and breast, resulting in rapid and precise radiology reports. By identifying, measuring, and characterizing nodules, See-Mode produces a comprehensive TI-RADS sonographer worksheet along with initial impressions for radiologists. In the realm of breast imaging, the software not only detects lesions but also automates the BI-RADS reporting process, offering detailed insights into lesion characteristics and levels of suspicion. This advanced technology minimizes inter-operator variability and reduces the likelihood of reporting errors, ultimately strengthening diagnostic confidence and ensuring consistency. By streamlining the reporting process, See-Mode facilitates more informed clinical decisions, which can lead to better patient outcomes.

Ibex Medical Analytics stands at the forefront of AI-driven cancer diagnostics within the field of pathology. Our diverse team comprises entrepreneurs, data scientists, software engineers, and medical professionals united in our mission to revolutionize cancer diagnostics through artificial intelligence, ultimately enhancing patient care. As the volume of tests continues to rise annually, pathologists face significant challenges in delivering precise and timely analyses. To address this, Ibex harnesses the power of AI to create clinical-grade solutions that aim to identify cancer with the same level of accuracy as a human pathologist. The Galen Platform employs advanced algorithms to scrutinize images, detect and classify cancer in biopsy samples, and highlight other clinically significant findings, thereby assisting pathologists in minimizing diagnostic errors while streamlining their workflow. Notably, Ibex’s Galen™ Prostate and Galen™ Breast solutions represent the pioneering AI-based cancer detection tools integrated into routine clinical practice in pathology labs, showcasing proven efficacy in uncovering previously missed cancer cases. As we continue to innovate, our commitment to improving cancer detection and patient outcomes remains unwavering.